SPONSOR
Linnaeus Therapeutics, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 2, Phase 3
Conditions studied: Solid Tumor, AdultMelanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous MelanomaUnresectable Melanoma
NCT04130516 Phase 1, Phase 2
Recruiting
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
Solid Tumor, Adult
NCT06624644 Phase 2, Phase 3
Recruiting
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Melanoma (Skin Cancer)